<SEC-DOCUMENT>0001193125-16-681416.txt : 20160815
<SEC-HEADER>0001193125-16-681416.hdr.sgml : 20160815
<ACCEPTANCE-DATETIME>20160815084232
ACCESSION NUMBER:		0001193125-16-681416
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20160815
FILED AS OF DATE:		20160815
DATE AS OF CHANGE:		20160815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AEGON NV
		CENTRAL INDEX KEY:			0000769218
		STANDARD INDUSTRIAL CLASSIFICATION:	LIFE INSURANCE [6311]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10882
		FILM NUMBER:		161830206

	BUSINESS ADDRESS:	
		STREET 1:		AEGONPLEIN 50
		STREET 2:		PO BOX 85
		CITY:			THE HAGUE
		STATE:			P7
		ZIP:			2501 CB
		BUSINESS PHONE:		011-31-70-344-7308

	MAIL ADDRESS:	
		STREET 1:		AEGONPLEIN 50
		STREET 2:		PO BOX 85
		CITY:			THE HAGUE
		STATE:			P7
		ZIP:			2501 CB
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d240994d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Securities and Exchange Commission
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form 6-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Report of Foreign Issuer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Rule 13a-16 or 15d/16 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>August 2016 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>AEGON N.V.
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Aegonplein 50 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2591 TV
THE HAGUE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Netherlands </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aegon&#146;s press release, dated August&nbsp;15, 2016, is included as appendix and incorporated herein by
reference. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SIGNATURE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">AEGON N.V.</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">(Registrant)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: August&nbsp;15, 2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ J.O. van Klinken</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">J.O. van Klinken</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Executive Vice President and</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">General Counsel</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle">


<IMG SRC="g240994head01.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g240994gp001.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">The Hague &#150; August 15,
2016&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Aegon completes share buyback program </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aegon has completed the share buyback program announced on July&nbsp;4, 2016. This program neutralized the dilutive effect of the 2015 final dividend paid in
shares. The repurchased shares will be held as treasury shares and will be used to cover future stock dividends. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Between July&nbsp;4, 2016 and
August&nbsp;12, 2016 a total of 29,258,662 common shares were repurchased, at an average price of EUR 3.5054&nbsp;per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">More detailed information
about the program is available on <U>aegon.com/sharebuyback.</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">Media relations</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Investor relations</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">Debora de Laaf</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Willem van den Berg</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">+31 (0) 70 344 8730</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">+31 (0) 70 344 8405</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><U>gcc@aegon.com</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>ir@aegon.com</U></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Aegon&#146;s roots go back more than 170 years &#150; to the first half of the nineteenth century.
Since then, Aegon has grown into an international company, with businesses in more than 20 countries in the Americas, Europe and Asia. Today, Aegon is one of the world&#146;s leading financial services organizations, providing life insurance,
pensions and asset management. Aegon&#146;s purpose is to help people achieve a lifetime of financial security. More information: <U>aegon.com</U>. </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle">


<IMG SRC="g240994head01.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g240994gp002.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">The Hague &#150; August 15,
2016&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">Disclaimers </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary note regarding non-IFRS measures </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This document
includes the following non-IFRS financial measures: underlying earnings before tax, income tax, income before tax and market consistent value of new business. These non-IFRS measures are calculated by consolidating on a proportionate basis
Aegon&#146;s joint ventures and associated companies. The reconciliation of these measures, except for market consistent value of new business, to the most comparable IFRS measure is provided in note 3 &#145;Segment information&#146; of Aegon&#146;s
Condensed Consolidated Interim Financial Statements. Market consistent value of new business is not based on IFRS, which are used to report Aegon&#146;s primary financial statements and should not be viewed as a substitute for IFRS financial
measures. Aegon may define and calculate market consistent value of new business differently than other companies. Aegon believes that these non-IFRS measures, together with the IFRS information, provide meaningful information about the underlying
operating results of Aegon&#146;s business including insight into the financial measures that senior management uses in managing the business. In addition, return on equity is a ratio using a non-IFRS measure and is calculated by dividing the net
underlying earnings after cost of leverage by the average shareholders&#146; equity excluding the preferred shares, the revaluation reserve and the reserves related to defined benefit plans. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Local currencies and constant currency exchange rates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This document contains certain information about Aegon&#146;s results, financial condition and revenue generating investments presented in USD for the Americas
and Asia, and in GBP for the United Kingdom, because those businesses operate and are managed primarily in those currencies. Certain comparative information presented on a constant currency basis eliminates the effects of changes in currency
exchange rates. None of this information is a substitute for or superior to financial information about Aegon presented in EUR, which is the currency of Aegon&#146;s primary financial statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-looking statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The statements contained in
this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target,
intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, is confident, will, and similar expressions as they relate to Aegon. These statements are not guarantees of future performance and
involve risks, uncertainties and assumptions that are difficult to predict. Aegon undertakes no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking
statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and
uncertainties include but are not limited to the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes in the performance of financial markets, including emerging markets, such as with regard to: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The frequency and severity of defaults by issuers in Aegon&#146;s fixed income investment portfolios; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities Aegon holds; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The effects of declining creditworthiness of certain private sector securities and the resulting decline in the value of sovereign exposure that Aegon holds; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes in the performance of Aegon&#146;s investment portfolio and decline in ratings of Aegon&#146;s counterparties; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consequences of a potential (partial) break-up of the euro; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consequences of the anticipated exit of the United Kingdom from the European Union; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The frequency and severity of insured loss events; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes affecting longevity, mortality, morbidity, persistence and other factors that may impact the profitability of Aegon&#146;s insurance products; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reinsurers to whom Aegon has ceded significant underwriting risks may fail to meet their obligations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty
creditworthiness; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes in laws and regulations, particularly those affecting Aegon&#146;s operations&#146; ability to hire and retain key personnel, taxation of Aegon companies, the products Aegon sells, and the attractiveness of
certain products to its consumers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Regulatory changes relating to the pensions, investment, and insurance industries in the jurisdictions in which Aegon operates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Standard setting initiatives of supranational standard setting bodies such as the Financial Stability Board and the International Association of Insurance Supervisors or changes to such standards that may have an impact
on regional (such as EU), national or US federal or state level financial regulation or the application thereof to Aegon, including the designation of Aegon by the Financial Stability Board as a Global Systemically Important Insurer (G-SII);
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes in customer behavior and public opinion in general related to, among other things, the type of products also Aegon sells, including legal, regulatory or commercial necessity to meet changing customer
expectations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Acts of God, acts of terrorism, acts of war and pandemics; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes in the policies of central banks and/or governments; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Lowering of one or more of Aegon&#146;s debt ratings issued by recognized rating organizations and the adverse impact such action may have on Aegon&#146;s ability to raise capital and on its liquidity and financial
condition; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Lowering of one or more of insurer financial strength ratings of Aegon&#146;s insurance subsidiaries and the adverse impact such action may have on the premium writings, policy retention, profitability and liquidity of
its insurance subsidiaries; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The effect of the European Union&#146;s Solvency II requirements and other regulations in other jurisdictions affecting the capital Aegon is required to maintain; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Litigation or regulatory action that could require Aegon to pay significant damages or change the way Aegon does business; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As Aegon&#146;s operations support complex transactions and are highly dependent on the proper functioning of information technology, a computer system failure or security breach may disrupt Aegon&#146;s business,
damage its reputation and adversely affect its results of operations, financial condition and cash flows; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Customer responsiveness to both new products and distribution channels; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for Aegon&#146;s products; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes in accounting regulations and policies or a change by Aegon in applying such regulations and policies, voluntarily or otherwise, which may affect Aegon&#146;s reported results and shareholders&#146; equity;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Aegon&#146;s projected results are highly sensitive to complex mathematical models of financial markets, mortality, longevity, and other dynamic systems subject to shocks and unpredictable volatility. Should assumptions
to these models later prove incorrect, or should errors in those models escape the controls in place to detect them, future performance will vary from projected results. The impact of acquisitions and divestitures, restructurings, product
withdrawals and other unusual items, including Aegon&#146;s ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Catastrophic events, either manmade or by nature, could result in material losses and significantly interrupt Aegon&#146;s business; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Aegon&#146;s failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving and excess capital and leverage ratio management initiatives. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further details of potential risks and uncertainties affecting Aegon are described in its filings with the Netherlands Authority for the Financial Markets and
the US Securities and Exchange Commission, including the Annual Report. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, Aegon expressly disclaims any obligation or
undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Aegon&#146;s expectations with regard thereto or any change in events, conditions or circumstances on which any such
statement is based. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g240994gp001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g240994gp001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  S 1$# 2(  A$! Q$!_\0
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M117H'G!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% '1?"C_ )'_ $__ +:?^BVKV:O&?A1_R/\ I_\ VT_]%M7LU?/Y
MM_&7I^K/>RO^$_7]$%%%%>6>D%:O@7_D=]'_ .OZ#_T8M95:O@7_ )'?1_\
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M5^ O_1*?!O\ X BC_AVK\!?^B4^#?_ $444?VYF7_01/_P #E_F']AY=_P!
M\/\ P"/^0?\ #M7X"_\ 1*?!O_@"*/\ AVK\!?\ HE/@W_P!%%%']N9E_P!!
M$_\ P.7^8?V'EW_0/#_P"/\ D'_#M7X"_P#1*?!O_@"*/^':OP%_Z)3X-_\
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M!2_S'_8^ _Y\0_\  8_Y!_PP=\'?^B=^&O\ P&_^O5O0?V*_A/X8UJUU&Q\
M^&[>]L95G@E%J&,3J<JPSD9!P0>Q&:**)9MCFK.M/_P)_P"94<HP*=U1A?\
-PQ_R/4****\\] __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g240994gp002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g240994gp002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  U 1,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#OO^"T?QI\
M6-_P4(\8:/'XBUBWTOP_;Z?;6%M!=R116Z/8V\[X52!DR2N2>IR/05\I_P#"
MU?%'_0R:]_X,)?\ XJOH3_@L_P#\I*_B3_W#/_359U\NU_9W"F%HK)<):"_A
M4WLMW%-_>S^(^+L=B?[<QB]I+2K46[V4VDODM#>_X6KXH_Z&37O_  82_P#Q
M5'_"U?%'_0R:]_X,)?\ XJL&BOH/JM'^1?<CYWZ]B?\ GY+[W_F;W_"U?%'_
M $,FO?\ @PE_^*H_X6KXH_Z&37O_  82_P#Q58-%'U6C_(ON0?7L3_S\E][_
M ,S>_P"%J^*/^ADU[_P82_\ Q5'_  M7Q1_T,FO?^#"7_P"*K!HH^JT?Y%]R
M#Z]B?^?DOO?^9O?\+5\4?]#)KW_@PE_^*H_X6KXH_P"ADU[_ ,&$O_Q58-%'
MU6C_ "+[D'U[$_\ /R7WO_,WO^%J^*/^ADU[_P &$O\ \51_PM7Q1_T,FO?^
M#"7_ .*K!HH^JT?Y%]R#Z]B?^?DOO?\ F;W_  M7Q1_T,FO?^#"7_P"*H_X6
MKXH_Z&37O_!A+_\ %5@T4?5:/\B^Y!]>Q/\ S\E][_S-[_A:OBC_ *&37O\
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M\2?^X9_Z:K.OEVOJ+_@L_P#\I*_B3_W#/_359U\NU_9_"O\ R),'_P!>J?\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!H^$/^1LTO\
MZ^XO_0Q7N]>$>$/^1LTO_K[B_P#0Q7N]>%FWQQ]#V\J^"7J%%%%>0>J%%%%
M'[J_ C_DA_@W_L!6/_I.E%'P(_Y(?X-_[ 5C_P"DZ45_(^*_CS]7^9_:&%_@
M0]%^1Y5^TG_P3'^#_P"U=\0O^$J\7>'[N37G@2VFNK._EM3<H@PF]5.UF4<!
ML9P "2 ,>??\.+_V>O\ H Z__P"#N?\ QHHKUL/Q1G%"G&C1Q52,8JR2G))+
MLE<\G$<*Y-B*LJU?"TY2D[MN$6V^[=M0_P"'%_[/7_0!U_\ \'<_^-'_  XO
M_9Z_Z .O_P#@[G_QHHK;_7#//^@NI_X'+_,Q_P!3<A_Z J7_ (+C_D'_  XO
M_9Z_Z .O_P#@[G_QH_X<7_L]?] '7_\ P=S_ .-%%'^N&>?]!=3_ ,#E_F'^
MIN0_] 5+_P %Q_R#_AQ?^SU_T =?_P#!W/\ XT?\.+_V>O\ H Z__P"#N?\
MQHHH_P!<,\_Z"ZG_ ('+_,/]3<A_Z J7_@N/^0?\.+_V>O\ H Z__P"#N?\
MQH_X<7_L]?\ 0!U__P '<_\ C111_KAGG_074_\  Y?YA_J;D/\ T!4O_!<?
M\@_X<7_L]?\ 0!U__P '<_\ C1_PXO\ V>O^@#K_ /X.Y_\ &BBC_7#//^@N
MI_X'+_,/]3<A_P"@*E_X+C_D'_#B_P#9Z_Z .O\ _@[G_P :/^'%_P"SU_T
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MC_D'_#HSX+_] O6__!K)1_PZ,^"__0+UO_P:R445G_K-FW_03/\ \"?^9?\
MJKDW_0+3_P# (_Y!_P .C/@O_P! O6__  :R4Z+_ ()'_!>.56;2=9D52"5;
M59<-['!!_(T44?ZS9M_T$S_\"?\ F'^JN3?] M/_ , C_D?2.EZ9;Z)IEO96
@<,=O:V<2P0Q(,+$B@*J@>@  HHHKPVVW=GOI65D?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g240994head01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g240994head01.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ +0!^ P$1  (1 0,1 ?_$ )X   $$ P$! 0
M      @ !PD*! 4& P(+ 0 ! P4!                 0<( @,$!08)$
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MX(; <@?C4<L;\8_M\-_R=\W+KY(FR'E2&XCC0.2V@E/4X!)M<CA;APJ5[%&
M,)8,AV\#B#%E'QW&-B>VDC5Z]'QRXE[0)PL_(B,@Y$2AQRHJ<?C_ %'IDM[[
MH[B[DG.3OV;DY<S'B9'9A^RWTC]@*>[8^U>V^V8!C;!@XV)"!;^VBJ?W:VH_
MN33O=:&M_7FKV^TIW)^Z4"&,*7:!Q4[0[NT"CZ&$1#T#^O2@7('*D)L">=#]
M3,\5JV6"Q0,A2;?10JTBC!RTQ>H-"OPP6!W'PTQ'P+-\Z6!-])OX:?:NDDT^
MX3)'']0'KKMS[/RMNPX<N')Q<OW"%T2!^H_3#.C2,H'I57C923XBN+VGO;#W
M/-GPI\7+P_;2"-WR$Z4?5*QNL:L39G:.1' ','RIS2WG'1H]_*A:*I_&Q;P8
M^1?#)QA6S)\ =WTCE4RH$2<"7U @_,(?#K1'9MV$R8_MI^M(NI5T-=E_4"W$
M>== -\V8P/DC*Q_;QMI9M:V5OZ2;\#Y5B3>1<;5]DY?R=DKB23:M/K>9--VR
M6<K5R.9+R+J5;-TC&4<-"LVQS@8H"!@*/'5S%V+=\R58H,>4LTZP_*0!(S!0
MA)%@;D"WA5O+[AV3!A:;(R80JX[3VU DQ*I8N #<KI!-QSK3T+*E*O4)5I4#
M,:\_N,6I-P5<FGD2G.NX8#*BA(%9H.%1%%PV3]T #D2E'YN! >,G=NW-PVK*
MR,?29HL:0))(BMH#\+K<@<0>'F>7,5B[+W1MN\X>-DAE@FRHS)'%(R"1DXV;
M2">! U>0Y\C6_6OV-4 0,M;J<D5RY59MS*3$04J[E$P$612,*_:H=(Y@*8 $
M>##Q\>L-=DWAB0N+D$JH)_MMP!Y$\/&LUM_V1 "^9C ,Q O(G$C@0./&QX'S
MKC\BYBJF/Z8SOR,!-7JL.W (GD*#%(V0K5,[DC%-RL#0X@9 []0J')1'A3D!
MXX'K9;+VOF[QN;;0TD.+G*M].0W3O8:K"XYZ1JX^%:K?>[L'9-I7>DBGS-N8
MVU8R]6W'2"=)Y:CIX>-=56LE5>=CU%G+M"M2D?&H2D]6+ Z91\_6&C@!%(9^
M/,X$T8/;P(]_ %Y !]?3K"S=CS\28)&IGQW<I'+&&:.4CGTVMZOVK88'<&W9
ML)>1Q!DI&'DBE95DB!Y=5;^C]^5;&.R'0Y<RY8NY5F0,VCW$JY!I-QZXMXUH
MI[3I\M[;@WM-6R@<'.;@I?UXZLS;-NV/8SXTZ:G""Z,+L>(4<.)/@/&KT&^;
M-DDC'RL=RJ%SID4V0&Q8V/  \R>5>R-[I3AC&R2%LKRL?,'<)Q3PLNQ%O(G:
M<_5D9J>_VN#->!]P"\^W_=QU2VT[FDKP/CS":,#6-#76_*XMPOX?KX56F\;2
M\,>0F3 8);Z&UK9M/S:3?C;QMR\:^4[[2%G,:R1MU<5=3!'2D4W3F8\ZLBFR
M,)79V92KB+@C<P"!A+R "'0=IW18WE;'G$<5M9T-9=7*_#A?PO2+O6T/)'$N
M5 9)02@#K=@OS:>/&WC:MZK+1:#=L[7DF*+5Z0RC-PHZ0(@Z3(R7DCJ-U3'
MBQ"1S51<1*(@"*9C_M 1ZQ5QYW=HU1S(IL0 ;CU!>(\/40OQ(',UF-E8R(LC
MR((W%U)86(TE[@^/I!;A_E!/(5L.K-7Z7112Z**7112Z**CKN!*:.:E?NUS
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M[)" 2QHO2G$9K>=64CG$.UN$0U0B0^I;8;@8IL\96*,E3]_\JN62BS,'7?\
MXG@]7,8;V86?,.<-T63<K(P<PN2_ YDC$-&R<.DO3EZB6]456<L[ )T3"&WG
M:&CVN[J4$Z )Q&#&BLLJ/QZS"6$QO?TRTW1FV1031&QS-J-0Q37&C)RM:9)P
MJ=6Y0,D6JK'MBA5F@Z?A:2/3$(F/U1A.(<%]LVZ#[+K/LHL?ZM<=?1*VLR\;
M]4=(6/U?VI2Y/IX \;C1&/?=*G/ER?HUC[?7$N@0\+=$F8W'T3W@DL!ZS<CA
%I/\ _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
